Form 4/A for TRLV Trulieve Cannabis Corp.
Accepted 2024-01-16 00:00:00 ET · period of report 2023-07-25 · accession 0001209191-24-001674 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2024-01-16 | 2023-07-25 | TRLV | Morey Timothy | Chief Sales Off | A - Grant | $0.00 | +53.7K | 84.1K | +177% | $0 |
| DA | 2024-01-16 | 2023-07-25 | TRLV | Morey Timothy | Chief Sales Off | A - Grant | $0.00 | +119.5K | 119.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2023-07-25 | A | A | 53,681 | $0.00 | 84,091 | D | — | — | (F1) The original Form 4 filed on July 27, 2023, is amended by this Form 4 amendment to correct column 5 (Amount of Securities Beneficially Owned Following Reported Transactions), which was incorrectly reported in the original filing due to a clerical error. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-07-25 | A | A | 119,454 | $0.00 | 119,454 | D | $3.99 · — to 2030-07-24 | 119,454 Subordinate Voting Shares | (F2) The original Form 4 filed on July 27, 2023, is amended by this Form 4 amendment to correct column 2 (Conversion or Exercise Price of Derivative Security), which was incorrectly reported in the original filing due to a clerical error. (F3) The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2023, one-third vesting on December 1, 2024, and one-third vesting on December 1, 2025. |